Literature DB >> 12461432

Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort).

Ignacio Suárez-Lozano1, José M Fajardo, Myriam Garrido, Bernardino Roca, M Luisa García-Alcalde, Paloma Geijo, Daniel Selma, Fernando Lozano, Ramón Teira, Pompeyo Viciana, Salvador Pérez-Cortés, Pere Domingo, Antonia Menchero, M José Galindo, Jaime Cosín, Esteban Ribera, José R Arribas, Juan R Lacalle.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12461432     DOI： 10.1097/01.aids.0000042931.55529.82

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

1.  Using a two-step method to measure transgender identity in Latin America/the Caribbean, Portugal, and Spain.

Authors:  Sari L Reisner; Katie Biello; Joshua G Rosenberger; S Bryn Austin; Sebastien Haneuse; Amaya Perez-Brumer; David S Novak; Matthew J Mimiaga
Journal:  Arch Sex Behav       Date:  2014-07-17

2.  Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort.

Authors:  Vicente Estrada; Paloma Geijo; Manuel Fuentes-Ferrer; María Luisa García Alcalde; María Rodrigo; María José Galindo; Agustín Muñoz; Pere Domingo; Esteve Ribera; Jaime Cosín; Pompeyo Viciana; Fernando Lozano; Alberto Terrón; Antonio Vergara; Ramón Teira; Josefa Muñoz-Sánchez; Bernardino Roca; Trinitario Sánchez; José López-Aldeguer; Elisabeth Deig; Francisco Vidal; Enric Pedrol; Manuel Castaño-Carracedo; Teresa Puig; Myriam Garrido; Ignacio Suárez-Lozano
Journal:  BMC Womens Health       Date:  2011-08-04       Impact factor: 2.809

3.  Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more.

Authors:  MaMercedes Nogueras; Gemma Navarro; Esperança Antón; Montserrat Sala; Manel Cervantes; MaJosé Amengual; Ferran Segura
Journal:  BMC Infect Dis       Date:  2006-11-06       Impact factor: 3.090

4.  Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort.

Authors:  Ramón Teira; Helena Diaz-Cuervo; Filipa Aragão; Manuel Castaño; Alberto Romero; Bernardino Roca; Marta Montero; Maria José Galindo; Maria Jose Muñoz-Sánchez; Nuria Espinosa; Joaquim Peraire; Elisa Martínez; Belén de la Fuente; Pere Domingo; Elisabeth Deig; María Dolores Merino; Paloma Geijo; Vicente Estrada; María Antonia Sepúlveda; Josefina García; Juan Berenguer; Adriá Currán
Journal:  Infect Dis Ther       Date:  2022-04-11

5.  [Descriptive aspects of HIV/AIDS in patients aged 50 years and over followed at the Treatment Center of Bafoussam - Cameroon].

Authors:  François-Xavier Mbopi-Kéou; Lucienne Dempouo Djomassi; Francisca Monebenimp
Journal:  Pan Afr Med J       Date:  2012-08-14

6.  Dyslipidemia and cardiovascular disease risk factor management in HIV-1-infected subjects treated with HAART in the Spanish VACH cohort.

Authors:  Domingo Pere; Suarez-Lozano Ignacio; Teira Ramón; Lozano Fernando; Terrón Alberto; Viciana Pompeyo; González Juan; Galindo M José; Geijo Paloma; Vergara Antonio; Cosín Jaime; Ribera Esteban; Roca Bernardino; Garcia-Alcalde M Luisa; Sánchez Trinitario; Torres Ferran; Lacalle Juan Ramón; Garrido Myriam
Journal:  Open AIDS J       Date:  2008-03-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.